SMS Pharmaceuticals Share Price Today

SMS Pharmaceuticals discloses AGM voting results; all resolutions pass

All seven resolutions at SMS Pharmaceuticals' 38th AGM passed with requisite majority. Dividend declaration and CMD re-appointment approved by shareholders. Public institutions voted against CMD re-appointment, but non-institutional investors supported it. Total eligible shareholders on cut-off date: 36,232.

SMS Pharmaceuticals to host investor meet with Emkay Global

SMS Pharmaceuticals will hold an investor meet on September 15, 2026. The group meeting is scheduled with Emkay Global Investors. Venue is Hyderabad for the analyst interaction. No unpublished price-sensitive information will be discussed.

SMS Pharmaceuticals schedules 38th AGM for September 29 via video conference

SMS Pharmaceuticals schedules its 38th AGM for September 29, 2026. The meeting will be held via video conferencing without physical presence. Remote e-voting runs from September 25 to September 28, 2026. Record date for dividend eligibility is fixed at September 22, 2026. Book closure period extends from September 23 to September 29, 2026.

SMS Pharmaceuticals files FY26 BRSR report detailing sustainability metrics

SMS Pharmaceuticals filed its FY26 BRSR report with stock exchanges on September 4, 2026. Turnover reached ₹886.87 crore with exports contributing 66% of total revenue. Scope 1 emissions fell to 35,552.99 metric tonnes while Scope 2 rose to 62,026.13. Water withdrawal declined sharply to 219,939.60 kiloliters from 296,576.95 in FY25. Zero workplace fatalities and lost-time injuries recorded for the fiscal year.

SMS Pharmaceuticals reschedules 38th AGM to September 29, 2026

SMS Pharmaceuticals moves its 38th AGM to September 29, 2026. Record date for dividend eligibility is set for September 22, 2026. Book closure runs from September 23 to September 29, 2026. Meeting will be conducted via Video Conferencing or OAVM.

SMS Pharmaceuticals Communicates TDS Provisions on Final Dividend of Rs.0.40 Per Share for FY 2025-26

SMS Pharmaceuticals Limited has communicated TDS provisions to shareholders regarding a proposed final dividend of Rs.0.40 per equity share of face value Rs.1 for FY 2025-26, recommended by the Board on May 22, 2026. The dividend is subject to approval at the 38th AGM on September 23, 2026, with September 16, 2026 set as the Record Date. Resident individual shareholders with valid PAN are subject to 10% TDS, while those without valid PAN face 20% TDS; resident non-individuals may qualify for Nil TDS on submission of prescribed documents. Non-resident shareholders are subject to 20% withholding tax under domestic law, with DTAA benefits available upon submission of required documentation by September 9, 2026.